Clinical Trial Update: Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing budesonide, mesalazine, and placebo in lymphocytic colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphocytic Colitis

Drugs mentioned

• Budesonide (BUDESONIDE)
• Mesalazine (mesalazine)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Lymphocytic Colitis | Phase 3 | Status: COMPLETED